Guidelines Development Group
The GDG will follow the GRADE approach in defining the healthcare question of interest (population of interest, interventions to be compared and patient-relevant outcomes- PICO), synthesizing the evidence and developing the recommendations for the Guidelines. This will be carried out within virtual working environments and in meetings organised every three months. The initial draft documents and the final versions before publication are subject of open calls for feedback launched online.
An external contractor, CCIb –Iberoamerican Cochrane Centre, supports the GDG for their tasks from literature review to drafting of recommendations.
Members and external experts
Dr. Annette Lebeau, MD, PhD, is a senior lecturer in pathology at the University Medical Center Hamburg-Eppendorf in Hamburg, Germany. She is also partner in a private group practice for pathology in Lübeck, Germany. Dr. Lebeau has been involved in the practice of pathology for more than 25 years and has a special interest and expertise in breast pathology. She earned her Postdoctoral Qualification (Habilitation, PhD) at the Ludwig-Maximilians-University in Munich, Germany, where she also completed her residency in anatomical pathology. Dr. Lebeau obtained her Doctor of Medicine and Medical Degree at the Medical University of Lübeck, Germany.
The research of Dr. Lebeau mainly focuses on prognostic and predictive factors in breast cancer as well as breast cancer progression. She has authored over 80 peer reviewed scientific publications and more than 45 book chapters.
Dr. Lebeau has been nationally and internationally active in quality assurance of breast pathology and the development of multidisciplinary guidelines for the diagnosis and treatment of breast cancer since the late 1990s. She is member of the Scientific Advisory Council of the German Mammography Screening Program, where she also serves as appointed reference pathologist. Since the early 2000s she has been involved in the development and update of the German GoR Level III guidelines for the early detection, diagnosis, treatment and follow-up care of breast cancer as a member of the expert committees and chair of the breast pathology working groups.